BlackRock, Inc. 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2024-10-07 4:08 pm Purchase |
2024-09-30 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
38,269,434 16.400% |
20,351,689![]() (+113.58%) |
Filing |
2024-01-26 11:49 am Purchase |
2023-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
17,917,745 7.900% |
2,816,464![]() (+18.65%) |
Filing |
2023-02-03 12:10 pm Purchase |
2022-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
15,101,281 6.900% |
9,347,461![]() (+162.46%) |
Filing |
2021-04-09 6:02 pm Purchase |
2021-03-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
5,753,820 4.700% |
330,121![]() (+6.09%) |
Filing |
2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | ADMA Biologics, Inc. ADMA |
BlackRock Inc. BLK |
5,423,699 5.700% |
1,250,938![]() (+29.98%) |
Filing |